HB 2811

86(R) - 2019
House Public Health
House Public Health

Vote Recommendation

  • Neutral
  • Neutral
  • Neutral
  • Neutral
  • Neutral


Four Price
Gary VanDeaver

Bill Caption

Relating to the prescribing of controlled substances and dangerous drugs for acute pain.

Fiscal Notes

According to the Legislative Budget Board, no fiscal impact to the state is anticipated. 

Bill Analysis

HB 2811 would add requirements for practitioners when prescribing controlled substances. This bill would direct the Texas Medical Board to oversee and implement a process for prescribers when creating a clinical plan to address a patient’s acute pain needs. The bill would require the prescriber to review a patient’s previous drug history. In addition, the bill would set out specific guidelines for practitioners to discuss the use of “dangerous drugs” with applicable patients. Under current law, "dangerous drug" includes prescriptions that are schedule I-IV. Patients who are at risk for comorbid psychiatric disorders would require additional review and consideration. Under this new law, a written treatment plan would be documented in the patient's medical record.

Furthermore, the bill would strengthen informed consent among eligible patients. In a circumstance of absence consent among a patient, the bill would require a legal guardian to be used as a surrogate.

HB 2811 also includes a provision that would exclude circumstances of palliative care, end of life care, chronic pain, or pain involving the treatment of cancer.

Vote Recommendation Notes

Texas Action remains neutral on HB 2811 as it does not relate to our liberty principles.